LATROBE AREA HOSPITAL
1. Target Overview & Investment Thesis
LATROBE AREA HOSPITAL is a 115-bed suburban community hospital in WESTMORELAND, PA with $155.4M in net patient revenue and a 7.7% operating margin. The hospital serves a payer mix of 17.7% Medicare, 1.4% Medicaid, and 80.9% commercial.
Thesis: Turnaround. Our ML models identify $11.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.7% to 15.1% (+736bps).
| Net Revenue HCRIS | $155.4M |
| Current EBITDA COMPUTED | $12.0M |
| Operating Margin COMPUTED | 7.7% |
| Occupancy HCRIS | 62.3% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 34.2% |
| Distress Probability ML | 44.5% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 7.7% places it above the state median. Among 100 size-comparable peers (58-230 beds), the median margin is -8.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (58-230), prioritizing same-state peers. 100 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LATROBE AREA HOSPITAL (Target) | PA | 115 | $155.4M | 7.7% |
| WILLIAMSPORT HOSPITAL & MEDICA | PA | 227 | $459.8M | -8.4% |
| ST LUKE HOSPITAL ANDERSON CAMP | PA | 193 | $433.0M | 20.6% |
| THE GETTYSBURG HOSPITAL | PA | 76 | $341.8M | 18.4% |
| ST. JOSEPH MEDICAL CENTER | PA | 132 | $334.8M | 13.2% |
| EPHRATA COMMUNITY HOSPITAL | PA | 115 | $291.8M | 3.8% |
| EINSTEIN MEDICAL CENTER MONTGO | PA | 175 | $276.3M | 6.9% |
| THE GOOD SAMARITAN HOSPITAL | PA | 145 | $269.5M | -5.0% |
| WILKES-BARRE GENERAL HOSPITAL | PA | 188 | $262.1M | -13.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.9M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $99K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $12.0M |
| + RCM Uplift | +$11.4M |
| Pro Forma EBITDA | $23.4M |
| Current Margin | 7.7% |
| Pro Forma Margin | 15.1% |
| WC Released (1x) | $6.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $18.4M | $193.3M | 10.51x | 60.1% |
| Base (11x exit) | 10.0x | 11.0x | $18.4M | $218.6M | 11.88x | 64.0% |
| Bull Case | 9.0x | 11.0x | $16.6M | $262.3M | 15.84x | 73.8% |
| Bull (12x exit) | 9.0x | 12.0x | $16.6M | $291.0M | 17.58x | 77.4% |
| Bear Case | 11.0x | 10.0x | $20.2M | $130.1M | 6.43x | 45.1% |
| Bear (11x exit) | 11.0x | 11.0x | $20.2M | $149.7M | 7.40x | 49.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 100 hospitals with 58-230 beds
- Same-state prioritization (n=101)
- Comp margins: P25=-19.5% / P50=-8.5% / P75=6.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.